节点文献

FGF2及TGF-β1与良性前列腺增生的研究进展

Correlation of FGF2 and TGF-β1 with benign prostatic hyperplasia: Progress in research

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 骆华魏强

【Author】 LUO Hua;WEI Qiang;Department of Urology, Deyang Second People’s Hospital;Department of Urology, West China Hospital, Sichuan University;

【通讯作者】 魏强;

【机构】 德阳市第二人民医院泌尿外科四川大学华西医院泌尿外科

【摘要】 良性前列腺增生(BPH)是老年男性中最常见的疾病之一。前列腺发育、生长过程受雄激素和生长因子的调控,其中前列腺上皮细胞和间质细胞分泌的生长因子起着关键作用。在成纤维细胞生长因子(FGF)家族和转化生长因子(TGF-β)家族中,FGF2和TGF-β1是前列腺中最具代表性的生长因子,它们参与前列腺细胞增殖、凋亡、迁移和分化等生物学过程的调控。因此,临床应用靶向FGF/TGF-β药物治疗BPH提供了理论基础。

【Abstract】 Benign prostatic hyperplasia(BPH) is a most common disorder in the elderly. The development and growth of the prostate are regulated by androgens and growth factors, and the latter are secreted by prostatic epithelial and mesenchymal cells and play a key role. As the family members of FGF and TGF-β, FGF2 and TGF-β1 are the most representative growth factors in the prostate, involved in the regulation of such biological processes as proliferation, apoptosis, migration and differentiation of prostate cells, which provides a theoretical basis for the clinical application of FGF-and TGF-β-targeted drugs in the treatment of BPH.

  • 【文献出处】 中华男科学杂志 ,National Journal of Andrology , 编辑部邮箱 ,2022年09期
  • 【分类号】R697.3
  • 【下载频次】29
节点文献中: 

本文链接的文献网络图示:

本文的引文网络